Ulcerative colitis in northern Portugal and Galicia in Spain

Inflammatory Bowel Diseases

Volumn 16, Issue 7, 2010, Pages 1227-1238

  Barreiro De Acosta, Manuel ^a,b   Magro, Fernando ^c,d,m   Carpio, Daniel ^a,f   Lago, Paula ^c,g   Echarri, Ana ^a,h   Cotter, José ^c,f   Pereira, Santos ^a,i   Gonçalves, Raquel ^c,j   Lorenzo, Aurelio ^a,b   Carvalho, Laura ^c,k   Castro, Javier ^a,h   Barros, Luisa ^c,f   Dias, Jorge Amil ^c,d   Rodrigues, Susana ^c,d   Portela, Francisco ^c,l   Dias, Camila ^e   Da Costa Pereira, Altamiro ^e   Alvaréz, María Victoria ^f   Carpintero, Pedro ^f   Dancausa, Lucía ^f   De Castro, María Luisa ^f   Villaverde, Alberto Fernández ^f   Hernández, Vicent ^f   Ares, David Martínez ^f   Cadilla, Jesús Martínez ^f   Ollero, Virginia ^f   Prada, José Ignacio Rodríguez ^f   Santos, Eva ^f   Dourado, Ramón Vázquez ^f   Vega, Pablo ^f   Nunes, Amadeu Corte Real ^f   Valente, Ana Isabel ^f   Vieira, Ana Isabel ^f   Duarte, Antónia ^f   Marques, António ^f   Queiroz, Antonio ^f   Ribeiro, Bernardino ^f   Duesca, Carolina ^f   Viveiros, Celeste Fátima ^f   Caetano, Cidalina ^f   Sequeira, Claudia ^f   Horta, David ^f   Gencsi, Edgar ^f   Monteiro, Estela ^f   Silva, Filipe Gomes ^f   Marinho, Glória ^f   Cardoso, Helder ^f   Vasconcelos, Helena ^f   Sousa, Helena ^f   Morna, Henrique ^f   Lopes, Horácio ^f   Bastos, Isabel ^f   Medeiros, Isabel ^f   Seves, Isabel ^f   Rosa, Isadora ^f   Baranda, João ^f   De Deus, João Ramos ^f   Lopes, J Godinho ^f   Freitas, João ^f   De Matos, J Pinto ^f   Reis, Jorge ^f   Vieira, Jorge ^f   Estevens, José ^f   Ribeiro, J M ^f   Matos, Leopoldo ^f   Correia, Luís ^f   Jasmins, Luís ^f   Lebre, Luis ^f   Gloria, Luísa ^f   Tavares, Lurdes ^f   Cravo, Marília ^f   Marques, Margarida ^f   Cremers, Marie Isabelle ^f   Maldonado, Maria Do Rosário ^f   Correia, Manuel ^f   De Lurdes Gonçalves, Maria ^f   César, Mário ^f   Areia, Miguel ^f   Ferreira, Manuela ^f   Campos, Mário Júlio ^f   Salgado, Marta ^f   Almeida, Nuno ^f   Andrade, Paulo ^f   Ministro, Paula ^f   Santos, Paula Moura ^f   Peixe, Paula ^f   Caldeira, Paulo ^f   Freire, Paulo ^f   Martins, Pedro ^f   Ferreira, Ricardo ^f   Freire, Ricardo ^f   Loureiro, Rui ^f   Sousa, Rui ^f   Cerqueira, Rute ^f   Sousa, Salazar ^f   Lima, Salomé Costa ^f   Alberto, Sara Folgado ^f   Leite, Silvia ^f   Mendes, Sofia ^f   Barroso, Sónia ^f   Lopes, Sandra ^f   Nobre, Sónia ^f   Bana E Costa, Tiago ^f   Fernandes, Vítor ^f   more..

^a EIGA (Inflammatory Bowel Disease Group of Galicia)   (Spain)

^b Instituto de Salud Carlos III   (Spain)

^c Portuguese Group of Studies of Inflammatory Bowel Diseases   (Portugal)

^d HOSPITAL DE SÃO JOÃO   (Portugal)

^e University of Porto   (Portugal)

^f Complexo Hospitalario of Pontevedra ^*

^g HOSPITAL DE SANTO ANTÓNIO   (Portugal)

^h Universidad de La Coruña   (Spain)

ⁱ HOSPITAL XERAL CÍES   (Spain)

^j HOSPITAL DE BRAGA   (Portugal)

^k Hospital de Vila Real   (Portugal)

^l CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

^m Fac Medicine   (Portugal)

more..

Author keywords

Biologic treatment; Clinical activity; Galicia; Immunosuppression; Montreal Classification; Portugal; Predictive factors; Southern Europe; Ulcerative colitis

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; MESALAZINE;

ADULT; AGED; ARTICLE; BIOLOGICAL THERAPY; DEMOGRAPHY; DISEASE PREDISPOSITION; DISEASE SEVERITY; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MALE; PORTUGAL; PRIORITY JOURNAL; RISK FACTOR; SPAIN; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; COLITIS, ULCERATIVE; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; MALE; PORTUGAL; PROGNOSIS; RISK FACTORS; SPAIN; YOUNG ADULT;

EID: 77953717409     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21170     Document Type: Article

References (46)

1. Shivananda S, Lennard-Jones J, Logan R, et al. Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Gut. 1996;39:690-697. (Pubitemid 26426470)
2. Magro F, Portela F, Lago P et al. A pharmaco-epidemiological approach to estimate IBD prevalence and incidence in Portugal. J Crohn's Colitis. 2008;2:35.
3. Saro Gismera C, Riestra Menéndez S, Milla Crespo A, et al. Incidence and prevalence of inflammatory bowel disease. Asturian study in 5 areas (EIICEA). Spain. An Med Interna. 2003;20:3-9.
4. Nerich V, Monnet E, Etienne A, et al. Geographical variations of inflammatory bowel disease in France: a study based on national health insurance data. Inflamm Bowel Dis. 2006;12:218-226.
5. Levenstein S, Li Z, Almer S, et al. Cross-cultural variation in disease-related concerns among patients with inflammatory bowel disease. Am J Gastroenterol. 2001;96:1822-1830.
6. Silverberg MS, Satsangi J, Ahmad T, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol. 2005;19:5-36.
7. Guimarães L, Freire JM. Health policy in the European Union: impact on the Spanish health system. Cad Saude Publica. 2007;23(suppl 2): S143-154.
8. Eikemo TA, Bambra C, Joyce K, et al. Welfare state regimes and income-related health inequalities: a comparison of 23 European countries. Eur J Public Health. 2008;18:593-599.
9. Loftus EV Jr, Schoenfeld P, Sandborn WJ. The epidemiology and natural history of Crohn's disease in population-based patient cohorts from North America: a systematic review. Aliment Pharmacol Ther. 2002;16:51-60.
10. Witte J, Shivananda S, Lennard-Jones JE, et al. Disease outcome in inflammatory bowel disease: mortality, morbidity and therapeutic management of a 796-person inception cohort in the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Scand J Gastroenterol. 2000;35:1272-1277.
11. Wolters FL, Russel MG, Sijbrandij J, et al. Disease outcome of inflammatory bowel disease patients: general outline of a Europe-wide population-based 10-year clinical follow-up study. Scand J Gastroenterol Suppl. 2006;243:46-54.
12. Hilsden RJ, Verhoef MJ, Best A, et al. A national survey on the patterns of treatment of inflammatory bowel disease in Canada. BMC Gastroenterol. 2003;3:10.
13. Brullet E, Bonfill X, Urrútia G, et al. Epidemiological study on the incidence of inflammatory bowel disease in 4 Spanish areas. Spanish Group on the Epidemiological Study of Inflammatory Bowel Disease. Med Clin (Barc). 1998;110:651-656.
14. Probert CS, Jayanthi V, Pinder D, et al. Epidemiological study of ulcerative proctocolitis in Indian migrants and the indigenous population of Leicestershire. Gut. 1992;33:687-693.
15. Linares de la Cal JA, Canton C, Pajares JM, et al. Inflammatory bowel disease in Argentina and Panama (1987-1993). Eur J Gastroenterol Hepatol. 1997;9:1129.
16. Manousos ON, Giannadaki E, Mouzas IA, et al. Ulcerative colitis is as common in Crete as in northern Europe: a 5-year prospective study. Eur J Gastroenterol Hepatol. 1996;8:893-898.
17. Henriksen M, Jahnsen J, Lygren I, et al. Are there any differences in phenotype or disease course between familial and sporadic cases of inflammatory bowel disease? Results of a population-based follow-up study. Am J Gastroenterol. 2007;102:1955-1963.
18. Lakatos L, Pandur T, David G, et al. Association of extraintestinal manifestations of inflammatory bowel disease in a province of western Hungary with disease phenotype: results of a 25-year follow-up study. World J Gastroenterol. 2003;9:2300-2307.
19. Vind I, Riis L, Jess T, et al. Increasing incidences of inflammatory bowel disease and decreasing surgery rates in Copenhagen City and County, 2003-2005: a population-based study from the Danish Crohn colitis database. Am J Gastroenterol. 2006;101:1274-1282.
20. Ladas SD, Mallas E, Giorgiotis K, et al. Incidence of ulcerative colitis in Central Greece: a prospective study. World J Gastroenterol. 2005;11:1785-1787. (Pubitemid 40520768)
21. Russel MG, Dorant E, Volovics A, et al. High incidence of inflammatory bowel disease in The Netherlands: results of a prospective study. The South Limburg IBD Study Group. Dis Colon Rectum. 1998;41:33-40.
22. Kappelman MD, Rifas-Shiman SL, Kleinman K, et al. The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States. Clin Gastroenterol Hepatol. 2007;5:1424-1429.
23. Timmer A, Goebell H. Incidence of ulcerative colitis, 1980-1995 - a prospective study in an urban population in Germany. Z Gastroenterol. 1999;37:1079-1084.
24. Torres EA, De Jesús R, Pérez CM, et al. Prevalence of inflammatory bowel disease in an insured population in Puerto Rico during 1996. Health Sci J. 2003;22:253-258.
25. Bernstein CN, Blanchard JF, Rawsthorne P, et al. Epidemiology of Crohn's disease and ulcerative colitis in a central Canadian province: a population-based study. Am J Epidemiol. 1999;149:916-924. (Pubitemid 29230706)
26. Johnston RD, Logan, RF. What is the peak age for onset of IBD? Inflamm Bowel Dis. 2008;14:S2-S5.
27. Grimm IS, Friedman LS. Inflammatory bowel disease in the elderly. Gastroenterol Clin North Am. 1990;19:361-389.
28. Solberg IC, Lygren I, Jahnsen J, et al. Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study). Scand J Gastroenterol. 2009;44:431-440.
29. Park SH, Kim YM, Yang SK, et al. Clinical features and natural history of ulcerative colitis in Korea. Inflamm Bowel Dis. 2007;13:278-283.
30. Faubion WA Jr, Loftus EV Jr, Harmsen WS, et al. The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study. Gastroenterology. 2001;121:255-260. (Pubitemid 32729372)
31. Langholz E, Munkholm P, Davidsen M, et al. Course of ulcerative colitis: analysis of changes in disease activity over years. Gastroenterology. 1994;107:3-11. (Pubitemid 24195339)
32. Hoie O, Wolters FL, Riis L, et al. Low colectomy rates in ulcerative colitis in an unselected European cohort followed for 10 years. Gastroenterology. 2007;132:507-515.
33. Cheung WY, Dove J, Lervy B, et al. Shared care in gastroenterology: GPs' views of open access to out-patient follow-up for patients with inflammatory bowel disease. Fam Pract. 2002;19:53-56. (Pubitemid 34173275)
34. Williams JG, Cheung WY, Russell IT, et al. Open access follow up for inflammatory bowel disease: pragmatic randomised trial and cost effectiveness study. BMJ. 2000;320:544-548.
35. D'Haens G, Baert F, van Assche G, et al. Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial. Lancet. 2008;371:660-667.
36. Etchevers MJ, Aceituno M, Sans M. Are we giving azathioprine too late? The case for early immunomodulation in inflammatory bowel disease. World J Gastroenterol. 2008;14:5512-5518.
37. Sandborn W, Rutgeerts P, Reinisch W, et al. One year data from the Sonic Study: a randomized, double-blind trial comparing infliximab and infliximab plus azathioprine to azathioprine in patients with Crohn's disease naive to immunomodulators and biologic therapy. Gastroenterology. 2009;136:A-116.
38. Rodríguez-D'Jesus A, Casellas F, Malagelada JR. Epidemiology of inflammatory bowel disease in the elderly. Gastroenterol Hepatol. 2008;31:269-273.
39. Triantafillidis J, Emmanoudilis A, Barbatzas C, et al. Ulcerative colitis in Greece: clinicoepidemiological data, course and prognostic factors in 413 consecutive patients. J Clin Gastroenterol. 1998;27:204-210.
40. Triantafillidis JK, Emmanouilidis A, Argyros N, et al. Ulcerative colitis in the elderly: clinical patterns and outcome in 51 Greek patients. J Gastroenterol. 2001;36:354-355.
41. Lau A, Chande N, Ponich T, et al. Predictive factors associated with immunosuppressive agent use in ulcerative colitis: a case-control study. Aliment Pharmacol Ther. 2008;28:606-613.
42. Romberg-Camps MJ, Dagnelie PC, Kester AD, et al. Influence of phenotype at diagnosis and of other potential prognostic factors on the course of inflammatory bowel disease. Am J Gastroenterol. 2009;104:371-383.
43. Bitton A, Peppercorn MA, Antonioli DA, et al. Clinical, biological, and histologic parameters as predictors of relapse in ulcerative colitis. Gastroenterology. 2001;120:13-20. (Pubitemid 32061864)
44. Satsangi J, Silverberg MS, Vermeire S, et al. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut. 2006;55:749-753.
45. Langholz E, Munkholm P, Davidsen M, et al. Changes in extent of ulcerative colitis: a study on the course and prognostic factors. Scand J Gastroenterol. 1996;31:260-266. (Pubitemid 126422244)
46. Markowitz J, Grancher K, Kohn N, et al. A multicenter trial of 6-mercaptopurine and prednisone in children with newly diagnosed Crohn's disease. Gastroenterology. 2000;119:895-902.